Columbia College Alumni Association

Close Search

You are here

AlumniTALK

AlumniTALK is a virtual speaker series through which prominent Columbia alumni share their knowledge, insights and wisdom on salient topics with the alumni community.

Claudia Rankine
Claudia Rankine and the Making of Citizen

Tuesday, October 27 | 6:00-7:30 p.m. EDT

In this exclusive AlumniTALK, author Claudia Rankine SOA'93 will read excerpts from and discuss her bestselling book Citizen: An American Lyric, which uses poetry, essay, cultural criticism and visual images to explore what it means to be an American citizen in a “post-racial” society.

Citizen is a vital work for our time. Don't miss this unique opportunity to engage in this urgent conversation around race and visibility with one of today's most significant and influential writers.

Joseph Goldstein CC'65 headshot
The Value of Mindfulness in Challenging Times with Joseph Goldstein CC'65

Check out Joseph Goldstein CC'65's conversation with Mila Atmos CC'96, SIPA'05 on how mindfulness can help relieve anxiety in periods of high stress and his guidance on how to practice it.

Dr. Vivian Mougios CC'96 and Dr. Valerie Purdie-Greenaway CC'93
Child Development: Neuropsychology of Parenting During Uncertainty

In the second AlumniTALK of the series, clinical psychologist Dr. Vivian Mougios CC'96 and Dr. Valerie Purdie-Greenaway CC'93 will discuss how the abrupt switch to distance learning and socializing is affecting children and parenting, and will share tangible tips that parents can use during this challenging time. They will also dive into how distance learning platforms should not be considered one-size-fits all by schools.

George Yancopoulos CC’80, GSAS’86, PS’87
Efforts to Fight COVID-19 with Dr. George D. Yancopoulos CC’80, GSAS’86, PS’87

In this exclusive AlumniTALK, Dr. George D. Yancopoulos CC’80, GSAS’86, PS’87, co-founder, president and chief scientific officer of Regeneron Pharmaceuticals, in conversation with Dean James J. Valentini, will discuss biotechnologies and therapy explorations aimed at addressing COVID-19, the most pressing public health infectious risk of our time.